Switching from Mounjaro (tirzepatide) to Wegovy (semaglutide) for weight loss is possible, but its something that should be guided by your healthcare provider
Since programs using semaglutide, tirzepatide, or phentermine are considered elective, most insurance plans do not provide coverage
Overall, the research didnt find that the GLP-1 was superior to the placebo at six months after treatment
Given the FDA's April 2026 proposal with a comment period closing June 29, 2026, this a real question for anyone starting a multi-month compounded GLP-1 program right now
Casi todo lo que sentimos, como el hambre o el sueo, es controlado por el cerebro
Surgical procedures are paid once, with long-lasting metabolic changes